NEOGENOMICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.14 USD | +2.09% |
|
+4.51% | -12.61% |
| 04-18 | NeoGenomics, Inc. Announces Senior Leadership Promotions | CI |
| 04-18 | NeoGenomics, Inc. Announces Eliminates of Position of Vishal Sikri, President, Advanced Diagnostics | CI |
Chart calendar NeoGenomics, Inc.
ef.odKW2PDw2fzo-NDiMizVIsZS8sYFl4408QW7F9u6clA.krPS6pi6hs7el6XSXRTnarU-lvZE29F4rknNbpPPPwrgmvS9gqe-jISZiQ~21c85283b9ea21f5815951f894f43e23
Upcoming events on NeoGenomics, Inc.
Past events on NeoGenomics, Inc.
| 10/04/2024 17:00 | American Association for Cancer Research Meeting - Poster No:20 |
| 09/04/2024 21:30 | American Association for Cancer Research Meeting - Poster No:10 |
| 09/04/2024 21:30 | American Association for Cancer Research Meeting - Poster No:30 |
| 09/04/2024 21:30 | American Association for Cancer Research Meeting - Poster No:16 |
| 09/04/2024 21:30 | American Association for Cancer Research Meeting - Poster No:5 |
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Poster No:8 |
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Poster No:35 |
| 08/04/2024 17:00 | American Association for Cancer Research Meeting - Poster No:26 |
| 08/04/2024 17:00 | American Association for Cancer Research Meeting - Poster No:30 |
| 07/04/2024 21:30 | American Association for Cancer Research Meeting - Poster No:30 |
| 07/04/2024 21:30 | American Association for Cancer Research Meeting - Poster No:17 |
| 05/03/2024 14:10 | TD Cowen Health Care Conference |
| 20/02/2024 21:30 | Q4 2023 Earnings Call |
| 20/02/2024 21:05 | Q4 2023 Earnings Release |
| 09/01/2024 01:15 | JPMorgan Healthcare Conference |
| 29/11/2023 14:00 | Piper Sandler Healthcare Conference |
| 06/11/2023 21:30 | Q3 2023 Earnings Call |
| 06/11/2023 21:05 | Q3 2023 Earnings Release |
| 08/08/2023 13:30 | Q2 2023 Earnings Call |
| 08/08/2023 12:00 | Q2 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 409 406 0.66% | 444 443 0.44% | 484 485 -0.06% | 510 501 1.72% | 592 589 0.47% | 655 |
|
EBITDA Million USD | Released Forecast Spread | 57,2 57,5 -0.45% | 34,8 33,1 5.34% | -4,16 -2,03 -104.55% | -48,0 -59,2 18.87% | 3,49 -2,22 256.78% | 22,7 |
|
EBIT Million USD | Released Forecast Spread | 13,0 14,8 -12.1% | -14,0 -11,3 -24.31% | -119 -101 -17.11% | -158 -163 3.4% | -108 -105 -2.56% | -87,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3,65 3,82 -4.51% | -14,1 -18,3 23.21% | -15,1 -3,98 -278.65% | -159 -172 7.52% | -97,1 -104 6.51% | -79,8 |
|
Net income Million USD | Released Forecast Spread | 8,01 3,52 127.49% | 4,17 -8,48 149.22% | -8,35 0,68 -1325.95% | -144 -158 8.6% | -88,0 -93,9 6.31% | -71,2 |
|
EPS USD | Released Forecast Spread | 0,08 0,04 122.22% | 0,04 -0,08 150.79% | -0,07 0,00 -4091.62% | -1,16 -1,27 8.66% | -0,70 -0,75 6.04% | -0,56 |
| Announcement Date | 27/02/20 | 24/02/21 | 23/02/22 | 23/02/23 | 20/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 126 126 -0.03% | 117 116 0.62% | 125 123 1.47% | 129 122 5.96% | 139 130 6.72% | 137 126 8.58% | 147 137 6.91% | 152 142 7.01% | 156 153 1.98% | 150 | 163 | 168 | 175 | 166 |
|
EBITDA Million USD | Released Forecast Spread | -9,79 -6,72 -45.53% | -19,0 -20,0 4.76% | -16,3 -18,8 13.37% | -11,6 -18,9 38.98% | -1,17 -11,7 90.06% | -7,12 -12,5 42.85% | -2,05 -8,34 75.4% | 3,31 -3,14 205.27% | 9,35 3,43 172.21% | -0,57 | 4,26 | 6,44 | 12,4 | 5,20 |
|
EBIT Million USD | Released Forecast Spread | -41,6 -29,3 -41.95% | -52,0 -40,8 -27.49% | -39,7 -41,5 4.23% | -39,5 -40,3 1.89% | -26,4 -36,7 28.18% | -35,1 -36,1 2.87% | -29,9 -31,5 5.06% | -24,2 -27,7 12.63% | -18,6 -21,3 12.79% | -27,7 | -23,0 | -21,2 | -15,4 | -22,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -44,2 -33,4 -32.39% | -53,2 -43,2 -23% | -41,0 -45,1 8.99% | -39,6 -44,2 10.29% | -25,5 -38,5 33.65% | -33,7 -39,3 14.27% | -26,6 -33,0 19.27% | -21,5 -29,3 26.8% | -15,3 -21,8 29.93% | -25,2 | -21,2 | -19,8 | -14,4 | -20,1 |
|
Net income Million USD | Released Forecast Spread | -41,8 -33,3 -25.55% | -49,4 -42,8 -15.33% | -35,3 -42,1 16.08% | -36,9 -41,8 11.77% | -22,7 -36,3 37.42% | -30,8 -35,9 14.28% | -24,3 -30,0 18.98% | -18,5 -26,7 30.76% | -14,3 -20,0 28.24% | -23,1 | -18,9 | -17,5 | -12,5 | -17,6 |
|
EPS USD | Released Forecast Spread | -0,34 -0,27 -25.15% | -0,40 -0,35 -15.94% | -0,28 -0,34 16.95% | -0,30 -0,33 9.43% | -0,18 -0,29 38.2% | -0,25 -0,29 12.28% | -0,19 -0,24 20% | -0,15 -0,21 29.05% | -0,11 -0,16 30.16% | -0,18 | -0,15 | -0,14 | -0,10 | -0,14 |
| Announcement Date | 23/02/22 | 27/04/22 | 09/08/22 | 08/11/22 | 23/02/23 | 08/05/23 | 08/08/23 | 06/11/23 | 20/02/24 | - | - | - | - | - |
| 28/04/2024 | SMO CLINPLUS CO.,LTD.: Q4 2023 Earnings Release |
| 29/04/2024 | NEOGENOMICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 12:00 | FULGENT GENETICS, INC.: Q1 2024 Earnings Release |
| 05/05/2024 | OPKO HEALTH, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | RADNET, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | SYNLAB AG: Q1 2024 Earnings Release |
| 08/05/2024 | FLEURY S.A.: Q1 2024 Earnings Release |
| 09/05/2024 | H.U. GROUP HOLDINGS, INC.: Q4 2023 Earnings Release |
| 09/05/2024 | BML, INC.: Q4 2023 Earnings Release |
| 09/05/2024 | GC CELL CORPORATION: Q1 2024 Earnings Release (Projected) |
Past sector events for NeoGenomics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NEO Stock
- Calendar NeoGenomics, Inc.
